Character | Response | |
---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Character | Response | |
---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
Class | Active | Resistant |
---|---|---|
|
|
|
|
|
|
Lineage | Physiology | General | Growth Tolerances | Hydrol./digest./degr. |
|
|
Health: Unknown
Source: human faeces (18-yr-old - CCUG), clinical sources (blood, urine, wound - CCUG) and rice paddies
DNA G+C(%): 65.1
|
High T(℃): 42(+)
NaCl >6%: 6.5(+)
|
|
---|
Monosaccharide O/F | Oligosaccharide O/F | Polysaccharide O/F | Polyol O/F | Other O/F |
|
|
|
|
|
---|
Monosaccharide util/assim | Oligosaccharide util/assim | Other carboh. util/assim | Amino acid util/assim | Organic acid util/assim |
|
|
|
|
|
---|
Enzymes: General | Enzymes: Carbohydrate | Enzymes: Protein | Enzymes: Arylamidases | Enzymes: Esters/fats |
|
|
|
|
|
---|
Fuel | Usable Metabolites | Metabolites Released | Special Products | Compounds Produced |
|
---|
Penicillins & Penems (μg/mL) | Cephalosporins (μg/mL) | Aminoglycosides (μg/mL) | Macrolides (μg/mL) | Quinolones (μg/mL) |
Augmentin: Var(MIC50): 2, MIC90: -
tica-clav: Var(MIC50): 2, MIC90: 64, RNG: (0.13->64)
imipenem: S(MIC50): 0.13, MIC90: 0.25, RNG: (0.13-2)
|
cefepime: Var(MIC50): 0.13, MIC90: 8, RNG: (≤0.06->64)
cefotetan: Var(MIC50): 2, MIC90: 32, RNG: (0.5->64)
ceftazidime: S(MIC50): 0.5, MIC90: 2, RNG: (0.13->64)
|
|
|
ciprofloxacin: Var(MIC50): ≤0.06, MIC90: 0.5, RNG: (≤0.06-0.5)
|
---|---|---|---|---|
Tetracyclines (μg/mL) | Vancomycin Class (μg/mL) | Polypep/ketides (μg/mL) | Heterocycles (μg/mL) | Other (μg/mL) |
|
|
|
|
|